Park Hyungjong, Han Minho, Kim Young Dae, Yoo Joonsang, Lee Hye Sun, Choi Jin Kyo, Heo Ji Hoe, Nam Hyo Suk
Department of Neurology, Yonsei University College of Medicine, Seoul 03722, Korea.
Department of Neurology, Keimyung University School of Medicine, Daegu 42601, Korea.
J Clin Med. 2019 Nov 7;8(11):1897. doi: 10.3390/jcm8111897.
Atrial fibrillation (AF) shares several risk factors with atherosclerosis. We investigated the association between total carotid plaque number (TPN) and long-term prognosis in ischemic stroke patients with AF.
A total of 392 ischemic stroke patients with AF who underwent carotid ultrasonography were enrolled. TPN was assessed using B-mode ultrasound. The patients were categorized into two groups according to best cutoff values for TPN (TPN ≤ 4 vs. TPN ≥ 5). The long-term risk of major adverse cardiovascular events (MACE) and mortality according to TPN was investigated using a Cox hazard model.
After a mean follow-up of 2.42 years, 113 patients (28.8%) had developed MACE and 88 patients (22.4%) had died. MACE occurred more frequently in the TPN ≥ 5 group than in the TPN ≤ 4 group (adjusted hazard ratio [HR], 1.50; 95% confidence interval [CI], 1.01-2.21; < 0.05). Moreover, the TPN ≥ 5 group showed an increased risk of all-cause mortality (adjusted HR, 2.69; 95% CI, 1.40-5.17; < 0.05). TPN along with maximal plaque thickness and intima media thickness showed improved prognostic utility when added to the variables of the CHADDS-VASc score.
TPN can predict the long-term outcome of ischemic stroke patients with AF. Adding TPN to the CHADDS-VASc score increases the predictability of outcome after stroke.
心房颤动(AF)与动脉粥样硬化有若干共同的危险因素。我们研究了缺血性卒中合并AF患者的颈动脉斑块总数(TPN)与长期预后之间的关联。
共纳入392例接受颈动脉超声检查的缺血性卒中合并AF患者。使用B型超声评估TPN。根据TPN的最佳截断值将患者分为两组(TPN≤4 vs. TPN≥5)。使用Cox风险模型研究根据TPN得出的主要不良心血管事件(MACE)和死亡率的长期风险。
平均随访2.42年后,113例患者(28.8%)发生了MACE,88例患者(22.4%)死亡。TPN≥5组的MACE发生率高于TPN≤4组(调整后风险比[HR],1.50;95%置信区间[CI],1.01 - 2.21;P<0.05)。此外,TPN≥5组的全因死亡率风险增加(调整后HR,2.69;95%CI,1.40 - 5.17;P<0.05)。当将TPN与最大斑块厚度和内膜中层厚度添加到CHADDS-VASc评分变量中时,其预后效用得到改善。
TPN可预测缺血性卒中合并AF患者的长期预后。将TPN添加到CHADDS-VASc评分中可提高卒中后结局的可预测性。